Luvometinib as a salvage therapy for a patient with PTPN11-positive juvenile myelomonocytic leukemia. Cheng J, Wei N, Lu Y, Gu J, et al. Leuk Res 2026;171:108329.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cheng J, Wei N, Lu Y, Gu J, et al. Luvometinib as a salvage therapy for a patient with PTPN11-positive juvenile myelomonocytic leukemia. Leuk Res 2026;171:108329.
PMID: 42843289